Home > Resources


Takeda offers helpful tools and resources for people living with primary immunodeficiency (PI). They're all available to you at no cost. Check out the resources below, which you can download or request now.

More About GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10%

Information for Patients

Learn more about primary immunodeficiency and treatment with GAMMAGARD LIQUID. You can download a PDF of this resource now.

Patient Product Brochure

 Download Full Prescribing

Learn more about primary immunodeficiency and connect with someone that is living with PI or has a loved one with PI. Visit us at MyIGSource.com or call 1-855-250-5111.

3rd-Party Organizations

Immune Deficiency Foundation (IDF)
The IDF is a national patient organization dedicated to improving the diagnosis, treatment, and quality of life of persons living with PI through advocacy, education, and research.

Jeffrey Modell Foundation (JMF)
A global patient organization devoted to early and precise diagnosis, meaningful treatments and ultimately, cures—through clinical and basic research, physician education, patient support, advocacy, public awareness and newborn screening. To learn more visit the Global PI Village®.

American Academy of Allergy, Asthma, and Immunology (AAAAI)
The AAAAI, a professional society for clinical immunologists, is a dedicated resource for information about PI. Search for PI under the list of conditions to find links to facts about PI, as well as support organizations and helpful guides. The site also has a tool to search for an allergy/immunologist near you.

Clinical Immunology Society (CIS)
The CIS is a professional society for clinical immunologists. The mission of the CIS is to facilitate education, translational research, and novel approaches to therapy in clinical immunology to promote excellence in care of patients with immunologic/inflammatory disorders.

Gammagard Liquid MyIgCoPayCard Program Terms and Conditions

This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law

Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.

To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.

Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.

Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.

This program is only valid for residents of the United States.

Shire reserves the right to change or discontinue this program at any time without notice.

This is not health insurance.


Add to patient instructions:

If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.

© 2017 Shire. All rights reserved.

SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.

S30515 04/17

Please expand for Indication and Important Safety Information.


What is the most important information that I should know about GAMMAGARD LIQUID?

GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.